Iran conflict impacts India's pharmaceutical supply chain
pre-market1 source ↓written by the desknot a recommendation
- pharmaceutical sector faces
- $50 billion
- of global generic
- 20%
- of US prescriptions
- 47%
- of which come
- 60%-70%
India's $50 billion pharmaceutical sector faces pressure due to the Iran war disrupting energy markets and trade routes. The country supplies 20% of global generic drug volumes, with 47% of US prescriptions filled by Indian manufacturers. This strain is exacerbated by reliance on imported active pharmaceutical ingredients (APIs), 60%-70% of which come from China.
Not investment advice. For informational purposes only.